Replies to post #423233 on NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

MiD,

I see the $15 million as a bridge between where we are now, and where we will be when the company has the authorization to increase it's shares from the shareholders. I can't say whether they go after that as soon as TLD is issued, or wait for the next Annual Meeting, but it's something they need to do to either bring in substantially more money, or take in an equity partner. I believe the $15 million is enough to carry them into Spring and by then the share price should be sufficient for the shareholders to support whatever they propose, it could be at the Annual Meeting, or they could call a special meeting at a time of their choosing.

Approvals initially require money to be spent in order to handle manufacturing, distribution and sales, as well as additional trials to expand the label for DCVax-L and get Direct going again. I would suspect hundreds of millions or more will be needed then, but at $5 or more a share it won't take that many to do it. If a partner comes in I believe they'll receive billions, so it won't be a concern, but it can't happen until substantially more shares are available so the partner owns a significant percentage of the company.

Gary

[Doc logic]

MI Dendream,

This is my sense of things as well. Just trying to determine if biosectinvestor was willing to admit moving in this thought direction as well since his stance had changed about the bag advertising issue. Way too much time has elapsed for NWBO not to be working towards getting this treatment leapfrogged to patients ASAP while negotiating the twists and turns of regulator guidance changes and suggestions for pathway forward and manufacturing ramp. I am sure there are those who work for the regulators that are just as frustrated with the “process” as anyone else and want patient access to treatments that work. Thanks for sharing your thoughts. Blessings and best wishes.